TY  - JOUR
AU  - Xie, Ruijie
AU  - Vlaski, Tomislav
AU  - Trares, Kira
AU  - Herder, Christian
AU  - Holleczek, Bernd
AU  - Brenner, Hermann
AU  - Schöttker, Ben
TI  - Large-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes.
JO  - Diabetes care
VL  - 48
IS  - 6
SN  - 0149-5992
CY  - Alexandria, Va.
PB  - Assoc.
M1  - DKFZ-2025-00713
SP  - 922-926
PY  - 2025
N1  - #EA:C070#LA:C070# / 2025 Jun 1;48(6):922-926
AB  - This study evaluated the incremental predictive value of proteomic biomarkers in assessing 10-year type 2 diabetes risk when added to the clinical Cambridge Diabetes Risk Score (CDRS).Data from 21,898 UK Biobank participants were used for model derivation and internal validation, and 4,454 Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung (ESTHER) cohort (Germany) participants were used for external validation. Proteomic profiling included the Olink Explore (2,085 proteins) and Olink Target 96 Inflammation panel (73 proteins).Adding 15 proteins from Olink Explore or 6 proteins from the Olink Inflammation panel improved the C-index of the CDRS by 0.029 or 0.016 in internal validation with net reclassification of 23.0
LB  - PUB:(DE-HGF)16
C6  - pmid:40178901
DO  - DOI:10.2337/dc24-2478
UR  - https://inrepo02.dkfz.de/record/300252
ER  -